Wolverine Asset Management LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Wolverine Asset Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $318,580 - $415,140	6,800 Added 755.56%	7,700 $453,000
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $1.3 Million - $1.57 Million	-24,100 Reduced 96.4%	900 $54,000
Q2 2017 Aug 14, 2017	BUY	N/A	25,000	25,000 $1.27 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.